Nyxoah SA Ordinary Shares NYXH

Morningstar Rating
$1.64 −0.07 (4.09%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NYXH is trading at a LOCK|!!Q<<< premium.
Price
$1.65
Fair Value
LOCK|n@@%WxR
Uncertainty
LOCK|K% Q#!>
1-Star Price
LOCK|%?W>>N&
5-Star Price
LOCK|n!DdDV
Economic Moat
LOCK|?t$
Capital Allocation

Trading Information

Previous Close Price
$1.71
Day Range
$1.641.72
52-Week Range
$1.268.59
Bid/Ask
$1.62 / $1.66
Shares Outstanding
100.07M
Market Cap
$164.12M
Volume/Avg
84,044 / 285,367

Key Statistics

Price/Earnings (Normalized)
Price/Sales
3.66
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
154

Valuation

Metric
NYXH
Price/Earnings (Normalized)
Price/Book Value
2.74
Price/Sales
3.66
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
NYXH
Quick Ratio
0.85
Current Ratio
0.99
Interest Coverage
−48.02
Quick Ratio
NYXH

Profitability

Metric
NYXH
Return on Assets (Normalized)
−72.47%
Return on Equity (Normalized)
−168.23%
Return on Invested Capital (Normalized)
−92.78%
Return on Assets
NYXH

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|Ms#<h#KZLOCK|JVG$144B
Becton Dickinson & Co
BDX
LOCK|GRLOCK|#Jk%T$42B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|>#bv$b#LOCK|?C@!$34B
Alcon Inc
ALC
LOCK|$g%fG!LOCK|?N@&$34B
ResMed Inc
RMD
LOCK|HcChp^wLOCK|Cssl$29B
West Pharmaceutical Services Inc
WST
LOCK|$SCm<>JLOCK|##$25B
The Cooper Companies Inc
COO
LOCK|xZ%FpcxLOCK|?jL^$14B
Solventum Corp
SOLV
LOCK|ShDY!l&LOCK|Ww<$13B
Align Technology Inc
ALGN
LOCK|!fB$GGLOCK|KC&$?$13B
Baxter International Inc
BAX
LOCK|>@LOCK|n?!T$12B

Sponsor Center